Kbc Group Nv Bio Techne Corp Transaction History

Kbc Group Nv

$32.2 Billion
Q1 2025

A detailed history of Kbc Group Nv transactions in Bio Techne Corp stock. As of the latest transaction made, Kbc Group Nv holds 13,442 shares of TECH stock, worth $676,804. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,442

Previous 19,043 29.41%

Holding current value

$676,804

Previous $1.37 Million 42.52%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	SELL	$58.47 - $78.75 $327,490 - $441,078	-5,601 Reduced 29.41%	13,442 $788,000
Q3 2024 Nov 06, 2024	BUY	$70.96 - $82.35 $397,446 - $461,242	5,601 Added 41.67%	19,043 $1.52 Million
Q2 2024 Jul 17, 2024	SELL	$62.12 - $84.15 $386,572 - $523,665	-6,223 Reduced 31.65%	13,442 $963,000
Q1 2024 May 08, 2024	SELL	$65.98 - $77.09 $1.49 Million - $1.74 Million	-22,545 Reduced 53.41%	19,665 $1.38 Million
Q4 2023 Feb 13, 2024	SELL	$52.83 - $78.22 $236,361 - $349,956	-4,474 Reduced 9.58%	42,210 $3.26 Million
Q3 2023 Feb 15, 2024	SELL	$67.52 - $89.42 $82,982 - $109,897	-1,229 Reduced 2.54%	47,157 $3.21 Million
Q2 2023 Feb 15, 2024	BUY	$73.76 - $85.98 $3.38 Million - $3.94 Million	45,817 Added 1783.46%	48,386 $3.95 Million
Q2 2023 Jul 28, 2023	BUY	$73.76 - $85.98 $2.43 Million - $2.83 Million	32,954 Added 240.01%	46,684 $3.81 Million
Q1 2023 Feb 14, 2024	SELL	$71.62 - $86.62 $112,371 - $135,906	-1,569 Reduced 9.0%	15,870 $1.18 Million
Q1 2023 May 04, 2023	BUY	$71.62 - $86.62 $803,218 - $971,443	11,215 Added 445.92%	13,730 $1.02 Million
Q4 2022 Feb 14, 2024	BUY	$80.67 - $352.29 $1.2 Million - $5.23 Million	14,855 Added 574.88%	17,439 $1.45 Million
Q3 2022 Feb 15, 2024	SELL	$282.54 - $391.85 $11.2 Million - $15.5 Million	-39,641 Reduced 93.91%	2,569 $729,000
Q2 2022 Feb 14, 2024	SELL	$322.67 - $449.65 $295,565 - $411,879	-916 Reduced 26.17%	2,584 $896,000
Q2 2022 Jul 26, 2022	SELL	$322.67 - $449.65 $317,829 - $442,905	-985 Reduced 28.14%	2,515 $872,000
Q1 2022 Feb 14, 2024	BUY	$353.85 - $487.79 $567,221 - $781,927	1,603 Added 84.5%	3,500 $1.52 Million
Q1 2022 May 06, 2022	BUY	$353.85 - $487.79 $567,221 - $781,927	1,603 Added 84.5%	3,500 $1.52 Million
Q4 2021 Feb 14, 2024	SELL	$456.15 - $525.06 $18.4 Million - $21.2 Million	-40,313 Reduced 95.51%	1,897 $981,000
Q4 2021 Feb 03, 2022	SELL	$456.15 - $525.06 $26 Million - $29.9 Million	-56,987 Reduced 96.78%	1,897 $981,000
Q3 2021 Nov 10, 2021	BUY	$444.87 - $538.88 $23.4 Million - $28.4 Million	52,638 Added 842.75%	58,884 $28.5 Million
Q2 2021 Aug 11, 2021	BUY	$387.35 - $450.26 $2.42 Million - $2.81 Million	6,246 New	6,246 $2.81 Million

Others Institutions Holding TECH

# of Institutions

613

Shares Held

155M

Call Options Held

161K

Put Options Held

12.7K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $1.97B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account